• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Biden Cancer Initiative Announces Oncology Clinical Trial Information Commons

Article

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons.

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons. The shared platform, which will be used to sore information on clinical trials and be accessed for patient matching and other data mining, will employ a single set of terms ad rules and a user-friendly interface for companies to enter and update information, such as patient selection criteria, trial locations, and patient participation requirements.

Founding members of the collaboration include BreastCancerTrials.org, Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Genospace/Sarag Cannon Research Center, IBM Watson Health, Massive Bio, and Syapse.

Read the full release.

Related Videos
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Kimberly Westrich, MA
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.